Ketorolac vs. Depomedrol Injections for Subacromial Impingement

How to Cite

OrthoEvidence. Ketorolac vs. Depomedrol Injections for Subacromial Impingement. ACE Report. 2022;228(1):1. Available from: https://myorthoevidence.com/AceReport/Report/14520

Study Type:Therapy

OE Level Evidence:1

Journal Level of Evidence:1

Outcomes of ketorolac versus depomedrol infiltrations for subacromial impingement syndrome: a randomized controlled trial

Musculoskelet Surg . 2022 Mar;106(1):29-34.

Contributing Authors:
T Goyal S Paul SS Sethy AK Choudhury

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Seventy patients with subacromial impingement syndrome were randomized to receive a subacromial depomedrol injection (n=35) or a subacromial ketorolac injection (n=35). The outcomes of interest included pain, function and range of motion at one and three month follow-up. There was no significant differences in pain as measured by a visual analogue scale. No differences in function between the two ...